BiotechTube

GFT505 80mg + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Impaired Glucose Tolerance

Conditions

Impaired Glucose Tolerance, Abdominal Obesity

Trial Timeline

Jun 1, 2009 → Jan 1, 2010

NCT ID
NCT01275469

About GFT505 80mg + Placebo

GFT505 80mg + Placebo is a phase 2 stage product being developed by Genfit for Impaired Glucose Tolerance. The current trial status is completed. This product is registered under clinical trial identifier NCT01275469. Target conditions include Impaired Glucose Tolerance, Abdominal Obesity.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (4)

NCT IDPhaseStatus
NCT01271777Phase 2Completed
NCT01261494Phase 2Completed
NCT01275469Phase 2Completed
NCT01271751Phase 2Completed

Competing Products

19 competing products in Impaired Glucose Tolerance

See all competitors
ProductCompanyStageHype Score
Aspirin + Alpha lipoic acid + Olmesartan + PlaceboDaiichi SankyoPre-clinical
23
ASP8825Astellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
GilteritinibAstellas PharmaPhase 1
33
fospropofol + fospropofol + fospropofol + fospropofolEisaiPre-clinical
23
Exenatide + MetforminEli LillyApproved
85
Apatinib MesylateJiangsu Hengrui MedicinePhase 1
33
balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg + balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg + dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozinAstraZenecaPhase 3
77
Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)MerckPre-clinical
23
ASA404NovartisPhase 1
33
MAS825 + Standard of Care (SoC)NovartisPhase 2
52
DFV890 + Standard of Care (SoC)NovartisPhase 2
52
Immediate switch to TDF/FTC/RPV + Switch to TDF/FTC/RPV after 24 weeksGilead SciencesApproved
84
Gabapentin + Gabapentin + Gabapentin + GabapentinPfizerApproved
84
Ramipril + RosiglitazonePfizerPhase 3
76
HSK7653 10mg Q2W + HSK7653 25mg Q2W + PlaceboHaisco Pharmaceutical GroupPhase 2
49
NBI-98854 50 mg capsuleNeurocrine BiosciencesPhase 1
30
BIS-001ERSupernus PharmaceuticalsPhase 1/2
36

Other Products from Genfit

Elafibranor + PlaceboPhase 3
69
VS-01 on top of SOCPhase 2
44
elafibranor 120mg + PlaceboPhase 2
44
GFT505 80mg + PlaceboPhase 2
44
Elafibranor 80mg + Elafibranor 120mgPhase 2
44